How many times should I follow up with a Team Lead (long time no contact)?

Wait until the review window you agreed on. If none was set, five business days. Send when you have a real trigger: news, a useful artifact, a role change, a season. After that, send a breakup note and archive it. A team lead who wants it will answer a clean close more often than a fifth bump.

Should I lower the price in the follow-up?

Not as an opening move. Ask what's blocking the decision first. If budget is the issue, trim scope or phase the work. Discounting before you know the objection trains them to wait you out. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it weird to email someone after six months of silence?

Not if you have a new reason and you don't pretend the old thread is still warm. Lead with the trigger, remind them who you are in one line, and make the ask optional. Nostalgia without news is just another cold email with extra steps.

Is it okay to send this proposal follow-up on LinkedIn instead of email?

Yes if this team lead is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals proposal follow-up?

Don't use consumer-startup slang. It's a credibility leak. CC'ing their skip-level to apply pressure. Don't open with 'it's been a while' and then paste the old pitch. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Pharmaceuticals · Team Lead · Long Time No Contact

Proposal Follow-Up for Pharmaceuticals Team Lead: Long Time…

A proposal follow-up email helps a stalled decision move without pretending the document didn't land. For Pharmaceuticals teams, the version that works for long time no contact has to respect Don't invent clinical claims. Write to the team lead like they already have a full calendar and a reason to be cautious.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this proposal follow-up work for a Pharmaceuticals Team Lead?

Offer a smaller package so budget isn't a binary wall.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a team lead actually reads: Very short. They'll read it between standups.
Bring a new observation about their world, then offer a small, optional next step.
Give them a clean no so they don't ghost out of politeness.

When should I send this to a Pharmaceuticals Team Lead?

Wait until the review window you agreed on. If none was set, five business days. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a team lead, Very short. They'll read it between standups. If they named a board week or a freeze, believe it and leave a reopen date.

What this Team Lead actually cares about

A team lead in Pharmaceuticals is protecting the team's focus and their own already-split calendar. They're in the tools all day. They care whether this creates more tickets for their people. Titles don't impress them. Friction does. The hook that earns a look is a daily annoyance, a broken workflow, or a report they have to build by hand. The ask should stay at this size: a 10-minute look or a sandbox, not an executive readout. Delete trigger: CC'ing their skip-level to apply pressure. Tone: Informal, useful, zero corporate fog.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Buyers here measure success with time through MLR, access, and compliant engagement rates. Buyers here measure success with time through MLR, access, and compliant engagement rates.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone informal, useful, zero corporate fog.
If legal is involved, ask for their redline format now.
Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this long time no contact note?

Asking 'any thoughts?' after a 12-page proposal invites silence.
Don't open with 'it's been a while' and then paste the old pitch.
Don't use consumer-startup slang. It's a credibility leak.
CC'ing their skip-level to apply pressure.

How does this long time no contact scenario compare?

Dimension	For this template
Best send window	Only when you have a trigger
Ideal length	Very short. They'll read it between standups.
Primary ask	a 10-minute look or a sandbox, not an executive readout
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Informal, useful, zero corporate fog.
Unlike no response	This isn't a 4-day bump. It's a re-introduction with a new reason.
Unlike breakup	You're opening a door, not closing one. Still keep it easy to ignore.

What should I copy and send?

Copy-ready template

Subject

Pharmaceuticals note on follow-up that ignores MLR, off-label risk,

Body

Hi [First Name],

Before this sits in a pile, I can cut [option] or split the rollout.

I'm writing because a label update, a launch window, or a congress. I left [optional module] as optional on purpose. We can ship [core] first and keep [nice-to-have] for later.

Re-earn a conversation, not restart a stale sequence at email 4.

Want a 10-minute walkthrough for whoever else needs to see it?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Name the situation and the business object, not your excitement. Something like "Pharmaceuticals note on follow-up that ignores MLR, off-label risk," outperforms "Just checking in" because a team lead can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Related templates

Want a custom draft instead? Try the email generator.